AXA S.A. - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2020$775,000
+40.9%
16,7000.0%0.00%0.0%
Q3 2020$550,000
-40.0%
16,700
-50.0%
0.00%0.0%
Q2 2020$916,000
-63.7%
33,400
-60.3%
0.00%
-66.7%
Q1 2020$2,520,000
+232.0%
84,200
-1.9%
0.01%
+100.0%
Q4 2018$759,000
-34.6%
85,795
-16.9%
0.00%
-25.0%
Q3 2018$1,161,000
-12.1%
103,1950.0%0.00%
-20.0%
Q2 2018$1,321,000
-7.7%
103,195
+21.8%
0.01%
-16.7%
Q1 2018$1,431,000
-73.3%
84,703
-87.3%
0.01%
-71.4%
Q4 2017$5,352,000
+3.1%
668,975
-0.1%
0.02%
-4.5%
Q3 2017$5,189,000
+4.0%
669,587
-1.4%
0.02%
-4.3%
Q2 2017$4,989,000678,7670.02%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MHR Fund Management 11,997,103$84,459,60511.88%
MPM BioImpact LLC 2,950,118$20,768,8314.18%
Perceptive Advisors 14,036,410$98,816,3262.86%
Velan Capital Investment Management LP 240,000$1,689,6001.57%
Parametrica Management Ltd 96,500$679,3601.31%
Boxer Capital, LLC 3,705,133$26,0841.21%
Soleus Capital Management, L.P. 1,239,777$8,728,0300.97%
Opaleye Management Inc. 421,000$2,963,8400.71%
683 Capital Management, LLC 1,400,000$9,856,0000.71%
RICE HALL JAMES & ASSOCIATES, LLC 1,758,759$12,381,6650.70%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders